location:Home > 2021 Vol.2 Mar.No1 > Analysis of blood lipid level and dietary factors in patients with cardiovascular and cerebrovascular diseases

2021 Vol.2 Mar.No1

  • Title: Analysis of blood lipid level and dietary factors in patients with cardiovascular and cerebrovascular diseases
  • Name: Hirai Keiji1,Taniguchi Setsu2
  • Company: (1.Jibei International University,High beam716-0009,Japan; 2.Chiba University of Science,Cho Tzu 288-0872,Japan)
  • Abstract:

    Objective: To understand the abnormal lipid metabolism of patients with cardiovascular and cerebrovascular diseases, and to explore the dietary factors affecting the level of blood lipids. Methods: A cross-sectional survey was conducted to collect 45 women with an age of (29.37 40.97) years and 45 men with an age of (30.28 41.69) years. The general data of all the subjects were collected by questionnaire, the intake of dietary nutrients was calculated by Logistic regression equation, the serum lipid level was detected by oxidase method, and the correlation between dietary factors and different lipid measurement indexes was analyzed. Results: The high-density lipoprotein cholesterol of women is higher than that of men, and the difference is statistically significant (P<0.05). Poultry, fried food and alcohol consumption are negatively correlated with high-density lipoprotein cholesterol (P<0.05). Conclusion: Age, poultry, fried food and alcohol consumption are the risk factors of hyperlipidemia.


  • Keyword: Cardiovascular and cerebrovascular diseases; Patients; Blood lipid level; Dietary factors; Cardiovascular risk factors
  • DOI: 10.12250/jpcarme2021010161
  • Citation form: Hirai Keiji1,Taniguchi Setsu2.Analysis of blood lipid level and dietary factors in patients with cardiovascular and cerebrovascular diseases.2020, vol. 3, 29-36.
Reference:

[1]Masateru T, Tsuyoshi Y, Koichi Akutsu, et al. Prevalence and predictors of coexistent silent atherosclerotic cardiovascular disease in patients with abdominal aortic aneurysm without previous symptomatic cardiovascular diseases[J].Angiology,2012,63(5):380-385.

[2]Henskens L H, van O R J, Kroon A A, et al. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients[J].Journal of hypertension,2009,27(4):846-853.

[3]Srjdan P, Robert S K, Jeffrey D K, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality[J].Archives of dermatology,2009,145(6):700-703.

[4]Hategan A, Hirsch C H. Cerebrovascular Steal Phenomenon and Electroconvulsive Therapy: A Case Report and Review of the Literature[J].The journal of ECT,2018,34(2):20-24.

[5]Gomez S Y H, Braganza M V, Daskalopoulou S S.Statin discontinuation in high-risk patients: a systematic review of the evidence[J].Current pharmaceutical design,2011,17(33):3669-3689.

[6]Takahashi H, Iinuma S, Honma M, et al. Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease[J].The Journal of dermatology,2014,41(11):981-985.


 


Tsuruta Institute of Medical Information Technology
Address:[502,5-47-6], Tsuyama, Tsukuba, Saitama, Japan TEL:008148-28809 fax:008148-28808 Japan,Email:jpciams@hotmail.com,2019-09-16